rs397516301
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM1PM2PP3_StrongPP5_Moderate
The NM_000260.4(MYO7A):c.3572G>A(p.Gly1191Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,598 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_000260.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYO7A | NM_000260.4 | c.3572G>A | p.Gly1191Asp | missense_variant | 28/49 | ENST00000409709.9 | NP_000251.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYO7A | ENST00000409709.9 | c.3572G>A | p.Gly1191Asp | missense_variant | 28/49 | 1 | NM_000260.4 | ENSP00000386331.3 | ||
MYO7A | ENST00000458637.6 | c.3572G>A | p.Gly1191Asp | missense_variant | 28/49 | 1 | ENSP00000392185.2 | |||
MYO7A | ENST00000409619.6 | c.3539G>A | p.Gly1180Asp | missense_variant | 29/50 | 1 | ENSP00000386635.2 | |||
MYO7A | ENST00000458169.2 | c.1115G>A | p.Gly372Asp | missense_variant | 8/29 | 1 | ENSP00000417017.2 | |||
MYO7A | ENST00000670577.1 | n.1412G>A | non_coding_transcript_exon_variant | 11/32 | ENSP00000499323.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 6.84e-7 AC: 1AN: 1461598Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727072
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Rare genetic deafness Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jun 30, 2011 | The Gly1191Asp variant in MYO7A has not been reported in the literature nor prev iously identified by our laboratory. However, identification of this variant in trans with another MYO7A in this individual?s son who has clinical features of U sher syndrome increases the likelihood that this variant is also pathogenic. In addition, this residue is conserved across species and computational analyses (P olyPhen2, SIFT) suggest that the Gly1191Asp variant may impact the protein. In s ummary, this variant is likely to be pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at